Gilead Sciences (GILD) PT Raised to $146 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst Andrew Berens raised the price target on Gilead Sciences (NASDAQ: GILD) to $146.00 (from $114.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
